Temozolomide for treating brain metastases

Seminars in Oncology

Volumn 28, Issue 4 SUPPL. 13, 2001, Pages 34-42

  Abrey, Lauren E ^a   Christodoulou, Christos ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ATHENS MEDICAL CENTER   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

TEMOZOLOMIDE;

ANTINEOPLASTIC ACTIVITY; BLOOD BRAIN BARRIER; BRAIN METASTASIS; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SAFETY; DRUG TOLERANCE; HUMAN; LEUKOPENIA; LIVER DISEASE; LUNG METASTASIS; NEUROLOGIC DISEASE; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THROMBOCYTOPENIA;

EID: 0034833541     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2001.26653     Document Type: Review

References (19)

1. Demographics of brain metastasis
2. The treatment of brain metastases from lung cancer
3. Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer?
4. Surgical treatment of 70 patients with brain metastases from breast carcinoma
5. Brain metastases in breast cancer: Prognostic factors abd management
6. Diagnosis of metastatic melanoma at distant sites
7. Brain metastases. Histology, multiplicity, surgery, and survival
8. Prognosis of patients treated for intracranial metastases with whole-brain irradiation
9. A phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies
10. Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies
11. Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignancies
12. A phase II study of temozolomide for recurrent brain metastases
13. Temozolomide (TMZ) in patients with brain metastases from solid tumors. A Hellenic Cooperative Oncology Group study
14. Temozolomide enhances radiation treatment efficacy in brain metastases: A randomized phase II study
15. Effect of temozolomide (TMZ) on central nervous system (CNS) relapse in patients with advanced melanoma
16. Temozolomide (TEM) and docetaxel (D) as first line chemotherapy in patients with advanced melanoma, a phase II study of Hellenic Cooperative Oncology group
17. Combination immunotherapy with Gm-CSF, IL-2, IFNα allows dose escalation of temozolomide with prevention of lymphocytopenia and brain metastases in metastatic malignant melanoma
18. Attenuation of O(6)-methylguanine-DNA methyltransferase activity and mRNA levels by cisplatin and temozolomide in jurkat cells
19. Cisplatin increases sensitivity of human leukemic blasts to triazine compounds